Jörg Trojan

Frankfurt Cancer Institute ORCID: 0000-0003-4110-2647

2

h-index

2

Publications

5,283

Citations

Publications

2 shown

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

Anthony B. El-Khoueiry , Bruno Sangro , Thomas Yau +18 more

2017 The Lancet 4168 citations

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister , Nicolás Gonzalo Núñez , Roser Pinyol +97 more

2021 Nature 1115 citations

Frequent Co-Authors

Anthony B. El-Khoueiry

USC Norris Comprehensive Cancer Center

Bruno Sangro

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Thomas Yau

University of Hong Kong

Todd S. Crocenzi

Providence Health & Services

Masatoshi Kudo

Kindai University

Chiun Hsu

National Taiwan University Hospital

Researcher Info

h-index: 2
Publications: 2
Citations: 5,283
Institution: Frankfurt Cancer Institute

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-4110-2647

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.